Teligent Inc (TLGT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | TLGT | TEVA | BBIO | RDY | SUPN |
| Company | Teligent Inc | Teva Pharmaceutical Industries ADR | Bridgebio Pharma Inc | Dr. Reddy's Laboratories Ltd ADR | Supernus Pharm |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NYSE | NASDAQ |
| Open | 0.2070 | 30.48 | 74.76 | 13.57 | 51.37 |
| High | 0.2090 | 30.71 | 75.68 | 13.66 | 52.69 |
| Low | 0.1650 | 30.10 | 73.19 | 13.43 | 51.32 |
| Latest | 0.1735 | 30.25 | 74.45 | 13.47 | 51.44 |
| Change | -0.0279 | +0.13 | +0.19 | -0.38 | -0.25 |
| % Change | -13.85% | +0.43% | +0.26% | -2.74% | -0.48% |
| Volume | 73,687,200 | 4,578,901 | 2,255,800 | 2,843,432 | 624,400 |
| 20-Day Average Volume | 14,124,449 | 7,608,700 | 2,050,995 | 2,324,380 | 633,855 |
| Previous Close | 0.2014 | 30.12 | 74.26 | 13.85 | 51.69 |
| Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.3321 | 29.81 | 70.05 | 13.98 | 50.90 |
| 20-Day Raw Stochastic | 3.24% | 48.34% | 88.15% | 8.06% | 50.27% |
| 20-Day Relative Strength | 25.55 | 47.15 | 55.55 | 42.74 | 51.56 |
| Weighted Alpha | -70.26 | +108.06 | +118.34 | +2.67 | +52.46 |
| Today's Opinion | 100% Sell | 24% Buy | 56% Buy | 72% Sell | 72% Buy |
| Previous Opinion | 100% Sell | 24% Buy | 48% Buy | 64% Sell | 88% Buy |
| Last Month's Opinion | 100% Sell | 56% Buy | 24% Buy | 8% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -44.64% since 10/08/21 | +2.68% since 03/25/26 | +3.97% since 03/25/26 | -2.88% since 03/25/26 | +2.76% since 03/25/26 |
| Low | 0.1650 on 10/15/21 | 28.28 on 03/30/26 | 68.83 on 03/30/26 | 13.37 on 03/30/26 | 48.85 on 03/30/26 |
| High | 0.3388 on 10/13/21 | 30.71 on 04/01/26 | 75.68 on 04/01/26 | 13.95 on 03/26/26 | 52.69 on 04/01/26 |
| 1-Month | |||||
| %Chg | -55.68% since 09/15/21 | -10.66% since 02/27/26 | +11.99% since 02/27/26 | -6.33% since 02/27/26 | -6.01% since 02/27/26 |
| Low | 0.1650 on 10/15/21 | 28.28 on 03/30/26 | 62.77 on 03/03/26 | 13.37 on 03/30/26 | 46.83 on 03/20/26 |
| High | 0.4275 on 09/30/21 | 34.20 on 03/02/26 | 75.90 on 03/10/26 | 14.61 on 03/10/26 | 56.49 on 03/04/26 |
| 3-Month | |||||
| %Chg | -65.30% since 07/15/21 | -3.08% since 12/31/25 | -2.67% since 12/31/25 | -4.06% since 12/31/25 | +3.50% since 12/31/25 |
| Low | 0.1650 on 10/15/21 | 28.28 on 03/30/26 | 62.77 on 03/03/26 | 12.81 on 01/20/26 | 46.83 on 03/20/26 |
| High | 0.6300 on 08/04/21 | 37.35 on 02/03/26 | 84.94 on 02/12/26 | 14.80 on 02/25/26 | 59.68 on 02/25/26 |
| 6-Month | |||||
| %Chg | -69.35% since 04/15/21 | +50.80% since 10/01/25 | +39.21% since 10/01/25 | -5.14% since 10/01/25 | +7.08% since 10/01/25 |
| Low | 0.1650 on 10/15/21 | 18.83 on 10/22/25 | 51.85 on 10/02/25 | 12.81 on 01/20/26 | 43.11 on 11/05/25 |
| High | 0.6579 on 06/14/21 | 37.35 on 02/03/26 | 84.94 on 02/12/26 | 14.95 on 10/22/25 | 59.68 on 02/25/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 16,104 | 34,632,368 | 14,396,268 | 11,559,681 | 2,976,414 |
| Shares Outstanding, K | 92,817 | 1,149,813 | 193,863 | 834,634 | 57,582 |
| Annual Sales | 45,310,000 | 17,258,000,000 | 502,080,000 | 3,811,000,000 | 718,950,000 |
| Annual Net Income | -122,020,000 | 1,411,000,000 | -724,930,000 | 663,000,000 | -38,550,000 |
| Last Quarter Sales | 10,430,000 | 4,711,000,000 | 154,180,000 | 977,400,000 | 211,570,000 |
| Last Quarter Net Income | -12,870,000 | 481,000,000 | -192,860,000 | 135,500,000 | -4,110,000 |
| 60-Month Beta | 1.61 | 0.72 | 1.13 | 0.34 | 0.70 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A on 08/16/21 | 0.96 on 01/28/26 | -1.00 on 02/24/26 | 0.16 on 01/21/26 | 0.92 on 02/24/26 |
| Latest Earnings Date | 10/03/22 | 04/29/26 | 05/05/26 | 05/08/26 | 05/05/26 |
| Most Recent Dividend | N/A | 0.072 on 11/27/17 | N/A | 0.071 on 07/25/25 | N/A |
| Next Ex-Dividends Date | N/A | 11/27/17 | N/A | 07/25/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 10.09 | 0.00 | 17.48 | 21.74 |